← Open Payments lookup

KRISTENE SMITH: Open Payments

NPI 1003521238 · GAITHERSBURG, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$939 in 32 payments from 10 companies in 2025. Trend: 2023 $1,033 · 2024 $814 · 2025 $939

Food & beverage: $939
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$338
Otsuka America Pharmaceutical, Inc.7$190
Vanda Pharmaceuticals Inc.4$113
ABBVIE INC.5$111
Lundbeck LLC3$61
Supernus Pharmaceuticals, Inc.2$45
Axsome Therapeutics, Inc.1$28
Takeda Pharmaceuticals U.S.A., Inc.1$22
OWP Pharmaceuticals, Inc.1$17
Collegium Pharmaceutical, Inc.1$15

Products named: CAPLYTA, REXULTI, FANAPT, VRAYLAR, Qelbree, ABILIFY ASIMTUFII, Auvelity, TRINTELLIX.

Industry payments across MD — which companies pay providers there.